Literature DB >> 15459762

[Aortic valve stenosis].

F A Flachskampf1, W G Daniel.   

Abstract

Aortic valve stenosis is the most frequent reason for prosthetic valve replacement in adults. Its incidence increases with age. Development of the most frequent form, degenerative-calcific aortic stenosis, is related to atherosclerotic risk factors. The narrowing of the aortic valve orifice leads to creation of a systolic pressure drop, the gradient, between left ventricle and ascending aorta. The pressure overload from aortic stenosis causes concentric left ventricular hypertrophy and later heart failure. Typical symptoms of severe aortic stenosis include dyspnea, angina, and dizziness or syncope. On auscultation, a loud systolic murmur over the base of the heart is apparent, which is transmitted to the carotids. The ECG often shows left ventricular hypertrophy. The most important diagnostic technique is echocardiography, which allows to measure the gradient and to calculate the orifice area, which determine the degree of severity. The development of symptoms or impaired left ventricular function in severe aortic stenosis should prompt surgical treatment by valve replacement. Truly asymptomatic patients with preserved left ventricular function should be followed conservatively.

Entities:  

Mesh:

Year:  2004        PMID: 15459762     DOI: 10.1007/s00108-004-1285-5

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  9 in total

1.  Determinants of mortality after cardiac surgery: results of the registry of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK) on 10 525 patients.

Authors:  A Vogt; E Grube; H G Glunz; K E Hauptmann; U Sechtem; W Mäurer; U Tebbe; K W Heinrich; H J Engel; W Kettner; W Krawietz; K L Neuhaus
Journal:  Eur Heart J       Date:  2000-01       Impact factor: 29.983

2.  Recommendations on the management of the asymptomatic patient with valvular heart disease.

Authors:  B Iung; C Gohlke-Bärwolf; P Tornos; C Tribouilloy; R Hall; E Butchart; A Vahanian
Journal:  Eur Heart J       Date:  2002-08       Impact factor: 29.983

3.  Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome.

Authors:  C M Otto; I G Burwash; M E Legget; B I Munt; M Fujioka; N L Healy; C D Kraft; C Y Miyake-Hull; R G Schwaegler
Journal:  Circulation       Date:  1997-05-06       Impact factor: 29.690

Review 4.  Balloon aortic valvuloplasty.

Authors:  A Wang; J K Harrison; T M Bashore
Journal:  Prog Cardiovasc Dis       Date:  1997 Jul-Aug       Impact factor: 8.194

5.  Predictors of outcome in severe, asymptomatic aortic stenosis.

Authors:  R Rosenhek; T Binder; G Porenta; I Lang; G Christ; M Schemper; G Maurer; H Baumgartner
Journal:  N Engl J Med       Date:  2000-08-31       Impact factor: 91.245

6.  Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics.

Authors:  Jean-Luc Monin; Jean-Paul Quéré; Mehran Monchi; Hélène Petit; Serge Baleynaud; Christophe Chauvel; Camélia Pop; Patrick Ohlmann; Claude Lelguen; Patrick Dehant; Christophe Tribouilloy; Pascal Guéret
Journal:  Circulation       Date:  2003-06-30       Impact factor: 29.690

7.  Current determinants of operative mortality in 1400 patients requiring aortic valve replacement.

Authors:  Ines Florath; Ulrich P Rosendahl; Amir Mortasawi; Stefan F Bauer; Fatmir Dalladaku; Ina C Ennker; Juergen C Ennker
Journal:  Ann Thorac Surg       Date:  2003-07       Impact factor: 4.330

8.  Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis.

Authors:  Alain Cribier; Hélène Eltchaninoff; Christophe Tron; Fabrice Bauer; Carla Agatiello; Laurent Sebagh; Assaf Bash; Danielle Nusimovici; P Y Litzler; Jean-Paul Bessou; Martin B Leon
Journal:  J Am Coll Cardiol       Date:  2004-02-18       Impact factor: 24.094

Review 9.  ACC/AHA guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association. Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease).

Authors: 
Journal:  J Am Coll Cardiol       Date:  1998-11       Impact factor: 24.094

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.